Zynex Inc.  

(Public, OTCMKTS:ZYXI)   Watch this stock  
Find more results for OTC:ZYXI
-0.002 (-1.33%)
Mar 30 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 0.14 - 0.15
52 week 0.06 - 0.50
Open 0.14
Vol / Avg. 3,669.00/7,427.00
Mkt cap 4.63M
P/E     -
Div/yield     -
EPS -0.36
Shares 31.27M
Beta -7.87
Inst. own 0%
Apr 2, 2015
Full Year 2014 Zynex Inc Earnings Call - 11:00AM EDT - Add to calendar
Mar 31, 2015
Full Year 2014 Zynex Inc Earnings Release Add to calendar

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin 6.09% -33.85%
Operating margin 9.36% -35.05%
EBITD margin - -31.18%
Return on average assets 10.58% -34.02%
Return on average equity - -86.24%
Employees 153 -
CDP Score - -


United States - Map
+1-303-7034906 (Phone)
+1-800-4956695 (Fax)

Website links


Zynex, Inc. is the parent company of and conducts business within five subsidiaries: Zynex Medical, Inc. (ZMI), Zynex Neurodiagnostics, Inc. (ZND), Zynex Monitoring Solutions, Inc. (ZMS), Zynex Billing and Consulting, LLC (ZBC), a limited liability company and Zynex International (Zynex Europe ApS) (ZEU). The Company operates in three business segments: ZMI and ZBC, ZND and ZEU, and ZMS. ZMI designs, manufactures and markets United States Food and Drug Administration (FDA) cleared medical devices. ZBC provides outsourced billing services for private medical practices. ZND was formed to market electromyography (EMG), electroencephalography (EEG), sleep pattern, auditory and nerve conductivity neurological diagnosis devices to hospitals and clinics across the world. ZEU was formed to progress Zynex�s international expansion. ZMS was formed to develop and market medical devices for non-invasive cardiac monitoring.

Officers and directors

Thomas Sandgaard Chairman of the Board, President, Chief Executive Officer
Age: 54
Brian Alleman Chief Financial Officer, Principal Financial Officer, Principal Accounting Officer
Age: 58